OnCo
technologiesTechnologyEmerging

Evo 2 (Arc Institute, NVIDIA)

A DNA language model trained on 9.3 trillion bases that can flag cancer-causing BRCA1 variants without being told about them.

Evo 2 (2025; 7B and 40B parameters, 1M-token context) predicts variant effects zero-shot, including BRCA1 pathogenicity, and generates genomic sequences; open weights.

Generic schematic · not to scale · placeholder for the ai computation front
Flagged finding · Neural network

How it works

StripedHyena long-context sequence model over nucleotides.

Strengths
  • Zero-shot variant effect
  • Open
Limitations
  • Human regulatory prediction weaker than specialised models
Since
2025

Latest papers

top
Latest papers · live from Europe PMC
Open in Europe PMC

Query for this technology: (TITLE:"Evo 2" OR ABSTRACT:"Evo 2" OR TITLE:"Arc Institute, NVIDIA" OR ABSTRACT:"Arc Institute, NVIDIA") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Evo 2 (Arc Institute, NVIDIA), not a curated reading list.

Connected

5top